Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | RXRA | P19793 | 5/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.51 |
| ▸ | RARA | P10276 | 4/20 | 0.51 |
| ▸ | RARB | P10826 | 4/20 | 0.51 |
| ▸ | RARG | P13631 | 4/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.51 |
| ▸ | RXRB | P28702 | 2/20 | 0.51 |
| ▸ | RXRG | P48443 | 2/20 | 0.51 |
| ▸ | RORC | P51449 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | HTR2B | P41595 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | DRD3 | P35462 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4389183 | 0.88 | MAPT (0.76) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL17769829 | 0.88 | MAPT (0.76) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL7088911 | 0.88 | MAPT (0.76) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL4389190 | 0.88 | MAPT (0.76) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL5905823 | 0.87 | MAPT (0.74) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL10067470 | 0.86 | MAPT (0.72) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL3389048 | 0.86 | MAPT (0.72) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL25378972 | 0.84 | MAPT (0.81) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL1578472 | 0.84 | MAPT (0.81) | MAPTALOX15ALDH1A1RXRACYP3A4 | |
| SCHEMBL3708856 | 0.84 | MAPT (0.81) | MAPTALOX15ALDH1A1RXRACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1968993-B1 | NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME | FABRE PIERRE DERMO COSMETIQUE (FR) | 2012-01-11 | — | — | EP | claimed |
| US-8481011-B2 | Use of polyunsaturated compounds as whitening agents | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-07-09 | — | — | US | disclosed |
| US-8481011-B2 | Use of polyunsaturated compounds as whitening agents | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-07-09 | — | — | US | disclosed |
| US-8420610-B2 | Polyunsaturated compounds, method for preparing same and compositions containing the same | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-04-16 | — | — | US | disclosed |
| US-8420610-B2 | Polyunsaturated compounds, method for preparing same and compositions containing the same | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2013-04-16 | — | — | US | disclosed |
| EP-1968993-B1 | NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME | FABRE PIERRE DERMO COSMETIQUE (FR) | 2012-01-11 | — | — | EP | disclosed |
| US-20100168045-A1 | Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-07-01 | — | — | US | disclosed |
| US-20100168045-A1 | Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-07-01 | — | — | US | disclosed |
| US-20090304614-A1 | Use of Polyunsaturated Compounds as Whitening Agents | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2009-12-10 | — | — | US | disclosed |
| US-20090304614-A1 | Use of Polyunsaturated Compounds as Whitening Agents | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2009-12-10 | — | — | US | disclosed |
| WO-2007068745-A1 | NOVEL POLYUNSATURATED COMPOUNDS, METHOD FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAME | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2007-06-21 | — | — | WO | disclosed |
| WO-2007068743-A1 | USE OF POLYUNSATURATED COMPOUNDS AS WHITENING AGENTS | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2007-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168045-A1 | Novel Polyunsaturated Compounds, Method for Preparing Same and Compositions Containing the Same | CBR3, CBR1, DECR1 | MAPT 4344/4885ALOX15 24/4885ALDH1A1 396/4885 |
| US-20090304614-A1 | Use of Polyunsaturated Compounds as Whitening Agents | FASN, ALOX5, ALOX15B | MAPT 2405/4885ALOX15 5/4885ALDH1A1 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.